# Pulmonary Thromboembolism at High Altitude in a Previously Healthy Adult: A Case Report

**Authors:** Rohini Kumari, Nidhi Kaeley, Aditya S Mahalle, Parina Tejpal, Sreevardhan Ambati

PMC · DOI: 10.7759/cureus.83001 · 2025-04-25

## TL;DR

A healthy man developed life-threatening pulmonary thromboembolism while at high altitude, highlighting the need for awareness of this condition in such settings.

## Contribution

This case report adds to the limited literature on pulmonary thromboembolism at high altitude in previously healthy individuals.

## Key findings

- A 54-year-old man with no comorbidities developed pulmonary thromboembolism at high altitude.
- Despite low clinical probability and negative D-dimer, CT pulmonary angiography confirmed the diagnosis.
- Treatment with apixaban led to recovery, emphasizing the importance of early suspicion and intervention.

## Abstract

Travel to high altitudes presents unique physiological challenges and can lead to various acute illnesses. Although pulmonary thromboembolism is infrequently documented in these settings, it can be life-threatening if unrecognized. A 54-year-old man with no known comorbidities developed sudden-onset shortness of breath and altered mental status while traveling at high altitudes. Initial evaluation revealed hypoxia, fever, and a markedly reduced ejection fraction on point-of-care ultrasound, with no deep vein thrombosis (DVT) on Doppler studies. Further imaging identified minimal pleural effusion and atelectasis on high-resolution computed tomography of the thorax. Despite a low clinical probability based on scoring systems and a negative D-dimer, clinical suspicion prompted a computed tomographic pulmonary angiography, which confirmed pulmonary thromboembolism in the right lower lobe pulmonary artery. Treatment with apixaban led to symptomatic improvement, and the patient was discharged in stable condition. This case highlights the need to consider pulmonary thromboembolism in the differential diagnosis of respiratory distress at high altitude, where hypoxia and other altitude-related factors may contribute to a hypercoagulable state.

## Linked entities

- **Chemicals:** apixaban (PubChem CID 10182969)

## Full-text entities

- **Diseases:** fever (MESH:D005334), Pulmonary Thromboembolism (MESH:D011655), shortness of breath (MESH:D004417), atelectasis (MESH:D001261), pleural effusion (MESH:D010996), acute (MESH:D000208), hypercoagulable (MESH:D019851), respiratory distress (MESH:D012128), DVT (MESH:D020246), hypoxia (MESH:D000860)
- **Chemicals:** apixaban (MESH:C522181)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12103908/full.md

---
Source: https://tomesphere.com/paper/PMC12103908